Stephen B. Porter

2.8k total citations
53 papers, 2.1k citations indexed

About

Stephen B. Porter is a scholar working on Endocrinology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Stephen B. Porter has authored 53 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Endocrinology, 28 papers in Molecular Medicine and 11 papers in Epidemiology. Recurrent topics in Stephen B. Porter's work include Antibiotic Resistance in Bacteria (28 papers), Escherichia coli research studies (26 papers) and Urinary Tract Infections Management (10 papers). Stephen B. Porter is often cited by papers focused on Antibiotic Resistance in Bacteria (28 papers), Escherichia coli research studies (26 papers) and Urinary Tract Infections Management (10 papers). Stephen B. Porter collaborates with scholars based in United States, Canada and New Zealand. Stephen B. Porter's co-authors include James R. Johnson, Brian Johnston, Bruce R. Blazar, Wayne R. Godfrey, Paul Thuras, Carl H. June, Bruce L. Levine, Connie Clabots, Michael A. Kuskowski and Ritu Banerjee and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Stephen B. Porter

53 papers receiving 2.1k citations

Peers

Stephen B. Porter
Andrea Marra United States
A Petit France
Zhi Ruan China
Hong Du China
Yukiko Nagano Japan
La‐Gen Wan China
Mark Pelletier United States
Seiichi Inamura Japan
Andrea Marra United States
Stephen B. Porter
Citations per year, relative to Stephen B. Porter Stephen B. Porter (= 1×) peers Andrea Marra

Countries citing papers authored by Stephen B. Porter

Since Specialization
Citations

This map shows the geographic impact of Stephen B. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Porter more than expected).

Fields of papers citing papers by Stephen B. Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen B. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Porter. The network helps show where Stephen B. Porter may publish in the future.

Co-authorship network of co-authors of Stephen B. Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen B. Porter. A scholar is included among the top collaborators of Stephen B. Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen B. Porter. Stephen B. Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Asrat, Seblewongel, Joseph C. Devlin, Andrea Vecchione, et al.. (2023). TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells. Cell Reports Methods. 3(7). 100522–100522. 7 indexed citations
2.
Porter, Stephen B., Brian Johnston, Dagmara Kisiela, et al.. (2022). Bacteriophage Cocktail and Microcin-Producing Probiotic Escherichia coli Protect Mice Against Gut Colonization With Multidrug-Resistant Escherichia coli Sequence Type 131. Frontiers in Microbiology. 13. 887799–887799. 21 indexed citations
3.
4.
Johnston, Brian, Paul Thuras, Stephen B. Porter, Mariana Castanheira, & James R. Johnson. (2021). Activity of meropenem/vaborbactam against international carbapenem-resistant Escherichia coli isolates in relation to clonal background, resistance genes, resistance to comparators and region. Journal of Global Antimicrobial Resistance. 24. 190–197. 12 indexed citations
5.
Johnston, Brian, Paul Thuras, Stephen B. Porter, et al.. (2021). Global molecular epidemiology of carbapenem-resistant Escherichia coli (2002–2017). European Journal of Clinical Microbiology & Infectious Diseases. 18 indexed citations
6.
Johnston, Brian, Paul Thuras, Stephen B. Porter, Connie Clabots, & James R. Johnson. (2021). Comparative activity of plazomicin against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–2017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and resistance to comparator agents. European Journal of Clinical Microbiology & Infectious Diseases. 40(10). 2069–2075. 2 indexed citations
7.
Johnson, James R., Giuseppe Magistro, Connie Clabots, et al.. (2018). Contribution of yersiniabactin to the virulence of an Escherichia coli sequence type 69 (“clonal group A”) cystitis isolate in murine models of urinary tract infection and sepsis. Microbial Pathogenesis. 120. 128–131. 14 indexed citations
8.
Johnson, James R., Brian Johnston, Stephen B. Porter, et al.. (2018). Accessory Traits and Phylogenetic Background Predict Escherichia coli Extraintestinal Virulence Better Than Does Ecological Source. The Journal of Infectious Diseases. 219(1). 121–132. 37 indexed citations
9.
Merino, Irene, Stephen B. Porter, Brian Johnston, et al.. (2017). Virulence genes and subclone status as markers of experimental virulence in a murine sepsis model among Escherichia coli sequence type 131 clinical isolates from Spain. PLoS ONE. 12(11). e0188838–e0188838. 8 indexed citations
10.
Kisiela, Dagmara, Matthew C. Radey, Sandip Paul, et al.. (2017). Inactivation of Transcriptional Regulators during Within-Household Evolution of Escherichia coli. Journal of Bacteriology. 199(13). 12 indexed citations
11.
Davis, Gregg S., Kara Waits, Lora Nordstrom, et al.. (2015). IntermingledKlebsiella pneumoniaePopulations Between Retail Meats and Human Urinary Tract Infections. Clinical Infectious Diseases. 61(6). 892–899. 102 indexed citations
12.
Liss, Michael A., James R. Johnson, Stephen B. Porter, et al.. (2014). Clinical and Microbiological Determinants of Infection After Transrectal Prostate Biopsy. Clinical Infectious Diseases. 60(7). 979–987. 47 indexed citations
13.
Vasoo, Shawn, Scott A. Cunningham, Jayawant N. Mandrekar, et al.. (2014). Prevalence of Rectal Colonization with Multidrug-Resistant Enterobacteriaceae among International Patients Hospitalized at Mayo Clinic, Rochester, Minnesota. Infection Control and Hospital Epidemiology. 35(2). 182–186. 5 indexed citations
14.
Williamson, Deborah A., Grant Mills, James R. Johnson, Stephen B. Porter, & Siouxsie Wiles. (2014). In vivo correlates of molecularly inferred virulence among extraintestinal pathogenicEscherichia coli(ExPEC) in the wax mothGalleria mellonellamodel system. Virulence. 5(3). 388–393. 28 indexed citations
15.
Williamson, Deborah A., Joshua T. Freeman, Stephen B. Porter, et al.. (2013). Clinical and molecular correlates of virulence in Escherichia coli causing bloodstream infection following transrectal ultrasound-guided (TRUS) prostate biopsy. Journal of Antimicrobial Chemotherapy. 68(12). 2898–2906. 23 indexed citations
16.
Banerjee, Ritu, Brian Johnston, Christine M. Lohse, et al.. (2013). Escherichia coliSequence Type 131 Is a Dominant, Antimicrobial-Resistant Clonal Group Associated with Healthcare and Elderly Hosts. Infection Control and Hospital Epidemiology. 34(4). 361–369. 111 indexed citations
17.
Breevoort, Sarah R., et al.. (2010). Modulation of the inhibitor properties of dipeptidyl (acyloxy)methyl ketones toward the CaaX proteases. Bioorganic & Medicinal Chemistry. 18(17). 6230–6237. 12 indexed citations
18.
Porter, Stephen B., et al.. (2007). Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1773(6). 853–862. 26 indexed citations
19.
Porter, Stephen B., Baoling Liu, John Rogosheske, et al.. (2006). Suppressor Function of Umbilical Cord Blood-Derived CD4+CD25+ T-Regulatory Cells Exposed to Graft-versus-Host Disease Drugs. Transplantation. 82(1). 23–29. 17 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Marra Breakdown of academic impact, for papers by A Petit Breakdown of academic impact, for papers by Zhi Ruan Breakdown of academic impact, for papers by Hong Du Breakdown of academic impact, for papers by Yukiko Nagano Breakdown of academic impact, for papers by La‐Gen Wan Breakdown of academic impact, for papers by Mark Pelletier Breakdown of academic impact, for papers by Seiichi Inamura
Rankless by CCL
2026